Ancora Advisors’s Evolent Health EVH Stock Holding History

Ancora Advisors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,194	Closed	-$34K	–	786
2018 Q3	$34K	Buy	+1,194	New	+$28.5K	﹤0.01%	973

Other funds holding EVH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Ancora Advisors's EVH Position: Q4 2018 in Review

Ancora Advisors sold out of Evolent Health (EVH) in Q4 2018, closing a stake of 1,194 shares — an estimated $34K sold.

Ancora Advisors first reported a position in EVH in Q3 2018 and held it in 1 quarter. The position peaked at $34K in Q3 2018. 186 funds tracked by Wall St. Rank hold EVH as of Q4 2018.

Ancora Advisors reported no remaining Evolent Health position as of Q4 2018 after selling out during the quarter.
Ancora Advisors sold 1,194 Evolent Health shares in Q4 2018, an estimated $34K.
Ancora Advisors first reported a position in Evolent Health in Q3 2018 and held it in 1 quarter.
Ancora Advisors's Evolent Health position peaked at $34K in Q3 2018.
186 funds tracked by Wall St. Rank held Evolent Health as of Q4 2018.

Based on Ancora Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.